Clinical Trials on Left Atrial Volume in Japan

Total 374 results

Nagoya University

Unknown

Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy (EARTH)

Hypertensive Left Ventricular Hypertrophy

Japan
Fresenius Kabi Japan

Completed

Study to Obtain Volume Effect and Safety Data on 6 % Hydroxyethyl Starch 130/0.4 in Pediatric and Adult Patients Undergoing Major Elective Surgery

Plasma Volume Substitution (Hypovolemia) Including Massive Hemorrhage

Japan
Otsuka Pharmaceutical Co., Ltd.

Recruiting

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of Tolvaptan in Pediatric Congestive Heart Failure (CHF) Patients With Volume Overload

Pediatric Congestive Heart Failure (CHF) Patients With Volume Overload

Japan
Okayama University
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Completed

Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease (PERSEUS)

Hypoplastic Left Heart Syndrome | Single Right Ventricle | Single Left Ventricle

Japan
Hiroaki Shimokawa, MD, PhD

Unknown

Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)

Heart Failure | Coronary Disease | Heart Valve Diseases | Cardiomyopathies | Left Ventricular Hypertrophy

Japan
Satoshi Shizuta
Daiichi Sankyo Co., Ltd.; Research Institute for Production Development

Completed

Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study (OAC-ALONE)

Coronary Artery Disease | Atrial Fibrillation

Japan
Japan Cardiovascular Research Foundation

Unknown

Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study (AFIRE)

Atrial Fibrillation

Japan
Pfizer

Completed

Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding

Non-valvular Atrial Fibrillation

Japan
Pfizer

Completed

Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation (CER3)

Non-valvular Atrial Fibrillation

Japan
Bristol-Myers Squibb

Completed

A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan

Non-Valvular Atrial Fibrillation (NVAF)

Japan
Mallinckrodt

Completed

Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgery

Hypertension, Pulmonary | Ventricular Dysfunction, Left

Japan
Kenichiro Yamagata

Completed

Ultrasound-guided Femoral Vein Accessibility, Safety and Time for Atrial Fibrillation Treatment (ULTRA-FAST)

Atrial Fibrillation | Peripheral Vascular Disease | Vascular Access Complications

Czechia, Japan
Pfizer

Completed

Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data

Non-valvular Atrial Fibrillation

Japan
Okayama University
National Cerebral and Cardiovascular Center

Completed

Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single Ventricle Physiology (TICAP)

Heart Failure | Hypoplastic Left Heart Syndrome | Single Ventricle

Japan
Pfizer

Completed

Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial Fibrillation

Non-valvular Atrial Fibrillation

Japan
Bayer
Janssen Scientific Affairs, LLC

Completed

Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan

Non-valvular Atrial Fibrillation (NVAF)

Japan
Arash Aryana, MD

Completed

Comparison of Pulmonary Vein Ablation With or Without Left Atrial Posterior Wall Ablation for Persistent AF (PIVoTAL) (PIVoTAL)

Persistent Atrial Fibrillation | Atrial Fibrillation Chronic

United States, Japan
Bristol-Myers Squibb
Pfizer

Completed

Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation

NonValvular Atrial Fibrillation

Japan
Metcela Inc.

Recruiting

Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial) (APOLLON)

Hypoplastic Left Heart Syndrome | Single Ventricle

Japan
Fujita Health University

Completed

Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS) (REWRAPS)

Coronary Artery Disease | Stroke | Atrial Fibrillation | All Cause Mortality | Fetal Blood Loss | Major Bleeding

Japan
Bayer

Completed

Bioequivalence Study of Rivaroxaban

Embolism, Atrial Fibrillation and Venous Thrombosis

Japan
Bayer

Completed

Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male Subjects

Embolism, Atrial Fibrillation and Venous Thrombosis

Japan
Institute for Clinical Effectiveness, Japan

Active, not recruiting

Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial (LEAP-AF)

Persistent Atrial Fibrillation | Catheter Ablation | Pulmonary Vein Isolation | Posterior Wall Isolation

Japan
Tohoku University

Unknown

Evaluation of Effectiveness and Safety of Xa Inhibitor for the Prevention of Stroke And Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-valvular Atrial Fibrillation (EXPAND)

Non-valvular Atrial Fibrillation

Japan
Daiichi Sankyo Co., Ltd.

Completed

Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment

Non-valvular Atrial Fibrillation

Japan
Acrobat Trial Group

Unknown

ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT) (ACROBAT)

Hypertension and Atrial Fibrillation

Japan
Boehringer Ingelheim

Completed

Japanese Pradaxa PMS, Long Term

Atrial Fibrillation

Japan
Boehringer Ingelheim

Completed

Comparative Effectiveness and Safety Between Warfarin and Dabigatran

Atrial Fibrillation

Japan
Daiichi Sankyo Co., Ltd.

Completed

Late Phase 2 Study of DU-176b in Patients With Non-Valvular Atrial Fibrillation

Atrial Fibrillation

Japan
Kyoto University, Graduate School of Medicine

Completed

Kansai Plus Atrial Fibrillation Trial (KPAF)

Atrial Fibrillation

Japan
Diagram B.V.
Johnson & Johnson; Biosense Webster, Inc.

Recruiting

CFAE/Spatiotemporal Dispersion Guided Ablation Versus PVI Guided Ablation in Persistent AF (CIPA)

Chronic Atrial Fibrillation

France, Netherlands, Japan
Cook Group Incorporated

Completed

Zilver Flex Post-Market Study in Japan

Peripheral Arterial Disease (PAD)

Japan
Sanofi

Completed

Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease

Peripheral Arterial Disease (PAD)

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)

Atrial Fibrillation

Japan
Japan Cardiovascular Research Foundation

Unknown

GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life Evidence (GENeRAL)

Atrial Fibrillation

Japan
Boehringer Ingelheim

Completed

Treatment Pattern of Oral Anticoagulants (OAC) in Japan

Atrial Fibrillation

Japan
Nagoya University

Unknown

Investigation of Genetic Risk of Atrial Fibrillation

Atrial Fibrillation

Japan
National Hospital Organization Minami Kyoto Hospital

Recruiting

Study on Optimal Oxygen Concentration During Pulmonary Rehabilitation

Chronic Respiratory Failure | Exercise Capacity | High-flow Nasal Cannula | Optimal SpO2 Value

Japan
GlaxoSmithKline

Withdrawn

Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects

Epilepsy, Partial

Japan
Boehringer Ingelheim

Completed

Medical Need of OAC Reversal

Atrial Fibrillation

Japan
AO Innovation Translation Center
AO Foundation, AO Spine

Recruiting

Primary Tumor Research and Outcomes Network (PTRON)

Spinal Column Tumor

United States, Canada, Italy, Australia, China, Germany, Hungary, Japan, United Kingdom
Boehringer Ingelheim

Completed

Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan

Atrial Fibrillation

Japan
Bristol-Myers Squibb
Pfizer

Completed

Evaluation of Safety and Effectiveness on Oral Anticoagulants (RCR-OAC)

Atrial Fibrillation

Japan
Bristol-Myers Squibb

Completed

Screening for Atrial Fibrillation (AF)-Potential Patients to Increase AF Detection Rate

Atrial Fibrillation

Japan
Ministry of Health, Labour and Welfare, Japan

Completed

Carvedilol Versus Metoprolol for the Prevention of Atrial Fibrillation After Off-Pump Coronary Bypass Surgery

Coronary Disease | Atrial Fibrillation

Japan
Tokai University
Daiichi Sankyo, Inc.

Unknown

Cerebral Microbleeds During NOACs or Warfarin Therapy in NVAF Patients With Acute Ischemic Stroke (CMB-NOW) (CMB-NOW)

Ischemic Stroke | Atrial Fibrillation Symptomatic

Japan
W.L.Gore & Associates

Completed

GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03)

Peripheral Arterial Disease

Japan
Kyorin University

Completed

Submacular Hemorrhage Associated With Retinal Arterial Macro Aneurysm

Submacular Hemorrhage | Ruptured Retinal Arterial Macro Aneurysms

Japan
Viatris Pharmaceuticals Japan Inc

Completed

Revatio Special Investigation for Long-term Use in Pediatric Patients

Pulmonary Arterial Hypertension

Japan
Medtronic Vascular

Completed

RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries (RJ-SVS)

Myocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Arterial Occlusive Diseases

Japan

3

Subscribe